United States· US:37662-1142_e537e1fc-3b8a-8ce1-e053-2a95a90a8005
Melilotus Officinalis
A medicinal product containing melilotus officinalis top, registered in United States by Hahnemann Laboratories, INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MELILOTUS OFFICINALIS TOP
- Manufacturer
- Hahnemann Laboratories, INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1137662-1142-1
- ndc1137662-1142-2
- ndc1137662-1142-3
- ndc1137662-1142-4
- ndc113766211421200 PELLET in 1 VIAL, GLASS (37662-1142-1)
- ndc113766211422500 PELLET in 1 VIAL, GLASS (37662-1142-2)
- ndc1137662114233000 PELLET in 1 BOTTLE, GLASS (37662-1142-3)
- ndc11376621142410000 PELLET in 1 BOTTLE, GLASS (37662-1142-4)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Melilotus officinalis top in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Poland · Plaster Nostrzykowy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edd0f163-1876-40da-9de6-323ad71a931e GET /v1/drugs/edd0f163-1876-40da-9de6-323ad71a931e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "MELILOTUS OFFICINALIS TOP",
"productndc": "37662-1142",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about melilotus officinalis top.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.